Mid-Year Update: SARS-CoV-2 Impact on the Life Sciences Real Estate Sector by Joseph Fetterman | 26 June 2020
COVID-19 Considerations for Healthcare Tenants, Landlords and Owners in the U.S. by Brian Bruggeman | 20 April 2020
In-house or Outsource? Considerations for Biotechs at Drug Manufacturing Decision Crossroads by Joseph Fetterman | 11 March 2020
A “Spark of Opportunity” Emerges in Colliers' Philadelphia New Life Sciences Report by Joseph Fetterman | 14 May 2019
